STEMI Treatment Optimization by Ischemic Postconditioning and IVUS Guidance

Recruiting N/A Interventional Study
ST Elevation Myocardial Infarction
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
2,500 (estimated)
Sponsor
Thomas Engstrom · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of is study is to investigate whether ischemic postconditioning (iPOST) and intravascular ultrasound-guided (IVUS) percutaneous coronary intervention (PCI) improve the clinical outcome of patients with ST-segment elevation myocardial infarction treated with primary PCI.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥18 years * Acute onset of chest pain with \<12 hours duration * STEMI as characterized by 2 mm ST elevation in 2 or more V1 through V4 leads or presumed new left bundle branch block with minimum of 1 mm concordant ST elevation or 1 mV ST-segment elevation in the limb lead…
Contacts

Thomas Engstrøm, MD PhD DSci

+45 3545 8444

Thomas.Engstroem@regionh.dk

CONTACT

Jacob Lønborg, MD PhD DMSci

+45 3545 8176

jacob.thomsen.loenborg01@regionh.dk

CONTACT